Sample result
Human insulin's gene
A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.
The search
- Query
- INS · 333 lettersATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGACCCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAGCTGGAGAACTACTGCAACTAG
- Search
- DNA → Patent DNA · Automatic (BLAST)
- Set
- Public patent sequences: Patent DNA, snapshot 2026-11-05-c456f6bdba29
- Ran
- 2026-11-12
- Found
- 3,194 sequences, 1,584 publications, 1,066 families
Each query returns up to 5,000 sequences and 5 alignments per sequence. BLAST may miss matches. These results do not establish patentability.
Patents
1,584 publications in 1,066 families match these filters.
-
EP 2305313-A22011-04-06
Remodelling and glycoconjugation of interferon-alpha (IFNa)
BIOGENERIX AG
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377333 of 333 identical, no gaps.
-
EP 2305314-A22011-04-06
Remodelling and glycoconjugation of antibodies
BIOGENERIX AG
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377333 of 333 identical, no gaps.
-
EP 2322229-A22011-05-18
Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF)
NOVO NORDISK AS
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377333 of 333 identical, no gaps.
-
JP 2011516037-A2011-05-26
Biomarkers
OTAGO INNOVATION LIMITED
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 60 to 392. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 60 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 119 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 120 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 179 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 180 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 239 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 240 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 299 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 300 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 359 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 360 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 392333 of 333 identical, no gaps.
-
EP 2338333-A22011-06-29
Glycopegylation methods and proteins/peptides produced by the methods
BIOGENERIX AG
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377333 of 333 identical, no gaps.
-
US 8008252-B22011-08-30
Factor VII: remodeling and glycoconjugation of Factor VII
Novo Nordisk A/S
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377333 of 333 identical, no gaps.
-
US 8063015-B22011-11-22
Glycopegylation methods and proteins/peptides produced by the methods
Novo Nordisk A/S
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377333 of 333 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- US 8063015-B22011-11-22
- US 8853161-B22014-10-07
-
US 8076292-B22011-12-13
Factor VIII: remodeling and glycoconjugation of factor VIII
Novo Nordisk A/S
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377333 of 333 identical, no gaps.
-
US 8129504-B22012-03-06
Oral delivery of modified transferrin fusion proteins
Biorexis Technology, Inc.
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377333 of 333 identical, no gaps.
-
US 8145437-B22012-03-27
System and method to obtain oligo-peptides with specific high affinity to query proteins
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 1 to 333. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333333 of 333 identical, no gaps.
-
EP 2465932-A22012-06-20
Organ-specific gene, method for identifying the same and use thereof
TAKEDA PHARMACEUTICAL
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 333, hit 36 to 368. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 36 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 95 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 96 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 155 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 156 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 215 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 216 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 275 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 276 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 335 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 336 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 368333 of 333 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- EP 2465932-A22012-06-20
- US 8535880-B22013-09-17
-
WO 2012100267-A12012-07-26
BIOMARKERS FOR RAPID DETERMINATION OF DRUG EFFICACY
IR2DX INC
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 60 to 392. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 60 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 119 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 120 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 179 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 180 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 239 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 240 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 299 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 300 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 359 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 360 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 392333 of 333 identical, no gaps.
-
JP 2013500744-A2013-01-10
TREATMENT OF INSULIN GENE (INS) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO AN INSULIN GENE (INS)
OPKO CuRNA LLC
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 60 to 392. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 60 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 119 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 120 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 179 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 180 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 239 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 240 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 299 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 300 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 359 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 360 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 392333 of 333 identical, no gaps.
-
US 8442773-B22013-05-14
Protein synthesis monitoring (PSM)
Anima Cell Metrology
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 60 to 392. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 60 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 119 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 120 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 179 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 180 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 239 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 240 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 299 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 300 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 359 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 360 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 392333 of 333 identical, no gaps.
-
JP 2013517329-A2013-05-16
Combination Theapy to Treat Autoimmune Diseases
Bayhill Therapeutics Inc,La Jolla Institute for Allergy and Immunology
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 1 to 333. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333333 of 333 identical, no gaps.
-
WO 2013151666-A22013-10-10
MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEINS ASSOCIATED WITH HUMAN DISEASE
MODERNA THERAPEUTICS
Query Match 100.0%Identity 100.0%Family of 53
Best alignment and family
Query 1 to 333, hit 234 to 566. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 234 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 293 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 294 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 353 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 354 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 413 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 414 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 473 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 474 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 533 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 534 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 566333 of 333 identical, no gaps.
Family of 53
Grouped by a shared priority claim, US 61/618862.
- WO 2013151666-A22013-10-10
- WO 2013151668-A22013-10-10
- WO 2013151736-A22013-10-10
- EP 2834358-A22015-02-11
- US 8999380-B22015-04-07
- JP 2015513912-A2015-05-18
- JP 2015513914-A2015-05-18
- JP 2015513916-A2015-05-18
- JP 2015516143-A2015-06-08
- JP 2015517995-A2015-06-25
- JP 2015518704-A2015-07-06
- JP 2015518705-A2015-07-06
- JP 2015518816-A2015-07-06
- JP 2015519040-A2015-07-09
- JP 2015519881-A2015-07-16
- US 9221891-B22015-12-29
- US 9254311-B22016-02-09
- US 9283287-B22016-03-15
- US 9303079-B22016-04-05
- US 9572896-B22017-02-21
And 33 more.
-
US 8716239-B22014-05-06
Granulocyte colony stimulating factor: remodeling and glycoconjugation G-CSF
Novo Nordisk A/S
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 45 to 377. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 45 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 104 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 105 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 164 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 165 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 224 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 225 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 284 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 285 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 344 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 345 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 377333 of 333 identical, no gaps.
-
JP 2014513938-A2014-06-19
CLONAL STRAINS OF ATTENUATED VACCINIA VIRUSES AND METHODS OF USE THEREOF
Genelux Corporation
Query Match 100.0%Identity 100.0%Family of 3
Best alignment and family
Query 1 to 333, hit 60 to 392. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 60 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 119 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 120 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 179 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 180 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 239 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 240 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 299 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 300 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 359 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 360 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 392333 of 333 identical, no gaps.
Family of 3
Grouped by a shared priority claim, US 61/517297.
- JP 2014513938-A2014-06-19
- JP 2018171059-A2018-11-08
- US 11149254-B22021-10-19
-
US 9095552-B22015-08-04
Modified polynucleotides encoding copper metabolism (MURR1) domain containing 1
Moderna Therapeutics, Inc.
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 234 to 566. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 234 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 293 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 294 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 353 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 354 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 413 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 414 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 473 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 474 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 533 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 534 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 566333 of 333 identical, no gaps.
-
US 9107886-B22015-08-18
Modified polynucleotides encoding basic helix-loop-helix family member E41
Moderna Therapeutics, Inc.
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 234 to 566. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 234 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 293 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 294 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 353 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 354 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 413 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 414 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 473 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 474 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 533 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 534 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 566333 of 333 identical, no gaps.
-
US 9114113-B22015-08-25
Modified polynucleotides encoding citeD4
Moderna Therapeutics, Inc.
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 234 to 566. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 234 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 293 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 294 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 353 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 354 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 413 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 414 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 473 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 474 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 533 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 534 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 566333 of 333 identical, no gaps.
-
US 9220792-B22015-12-29
Modified polynucleotides encoding aquaporin-5
Moderna Therapeutics, Inc.
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 234 to 566. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 234 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 293 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 294 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 353 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 354 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 413 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 414 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 473 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 474 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 533 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 534 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 566333 of 333 identical, no gaps.
-
US 9233141-B22016-01-12
Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders
Moderna Therapeutics, Inc.
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 234 to 566. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 234 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 293 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 294 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 353 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 354 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 413 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 414 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 473 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 474 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 533 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 534 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 566333 of 333 identical, no gaps.
-
US 9234199-B22016-01-12
Treatment of insulin gene (INS) related diseases by inhibition of natural antisense transcript to an insulin gene (INS)
CuRNA, Inc.
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 60 to 392. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 60 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 119 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 120 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 179 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 180 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 239 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 240 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 299 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 300 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 359 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 360 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 392333 of 333 identical, no gaps.
-
US 9453251-B22016-09-27
Expression of mammalian proteins in Pseudomonas fluorescens
PFENEX INC.
Query Match 100.0%Identity 100.0%Family of 3
Best alignment and family
Query 1 to 333, hit 1 to 333. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333333 of 333 identical, no gaps.
Family of 3
Grouped by the same title and applicant. No priority claim is on record.
- US 9453251-B22016-09-27
- US 9458487-B22016-10-04
- US 10041102-B22018-08-07
-
US 9630985-B22017-04-25
Biomarkers
Otago Innovation Limited
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 60 to 392. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 60 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 119 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 120 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 179 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 180 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 239 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 240 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 299 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 300 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 359 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 360 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 392333 of 333 identical, no gaps.
-
US 9657329-B22017-05-23
Propeptide-luciferase fusion proteins and methods of use thereof
The Broad Institute Inc., The General Hospital Corporation and Instituto Carlos slim de la Salud, A.C.
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 1 to 333. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333333 of 333 identical, no gaps.
-
US 9683215-B22017-06-20
Methods of reprogramming cells
President and Fellows of Harvard College
Query Match 100.0%Identity 100.0%Family of 3
Best alignment and family
Query 1 to 333, hit 60 to 392. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 60 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 119 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 120 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 179 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 180 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 239 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 240 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 299 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 300 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 359 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 360 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 392333 of 333 identical, no gaps.
Family of 3
Grouped by the same title and applicant. No priority claim is on record.
- US 9683215-B22017-06-20
- US 10221393-B22019-03-05
- US 11136554-B22021-10-05
-
WO 2018011805-A22018-01-18
SYSTEMS AND METHODS FOR GROWING CELLS IN VITRO
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIV OF JERUSALEM LTD
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 86 to 418. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 86 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 145 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 146 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 205 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 206 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 265 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 266 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 325 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 326 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 385 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 386 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 418333 of 333 identical, no gaps.
-
US 10106575-B22018-10-23
Biomarkers
Upstream Medical Technologies Limited
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 60 to 392. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 60 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 119 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 120 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 179 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 180 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 239 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 240 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 299 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 300 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 359 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 360 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 392333 of 333 identical, no gaps.
-
JP 2019505524-A2019-02-28
COMPOSITIONS AND METHODS FOR THE TREATMENT OF TYPE 1 DIABETES
INTREXON ACTOBIOTICS N V
Query Match 100.0%Identity 100.0%Family of 5
Best alignment and family
Query 1 to 333, hit 1 to 333. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333333 of 333 identical, no gaps.
Family of 5
Grouped by a shared priority claim, US 62/278493.
- JP 2019505524-A2019-02-28
- US 10905727-B22021-02-02
- US 11786567-B22023-10-17
- JP 2023166421-A2023-11-21
- US 12246046-B22025-03-11
-
KR 1020190021339-A2019-03-05
ENGINEERED PARASITES FOR DELIVERING PROTEIN TO THE CENTRAL NERVOUS SYSTEM (CNS)
RAMOT AT TEL-AVIV UNIVERSITY LTD.
Query Match 100.0%Identity 100.0%Family of 4
Best alignment and family
Query 1 to 333, hit 60 to 392. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 60 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 119 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 120 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 179 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 180 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 239 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 240 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 299 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 300 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 359 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 360 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 392333 of 333 identical, no gaps.
Family of 4
Grouped by a shared priority claim, US 62/355898.
- KR 1020190021339-A2019-03-05
- JP 2019525744-A2019-09-12
- JP 2022184996-A2022-12-13
- JP 2024112982-A2024-08-21
-
US 10370697-B22019-08-06
Propeptide-luciferase fusion proteins and methods of use thereof
THE BROAD INSTITUE, INC., THE GENERAL HOSPITAL CORPORATION and INSTITUTO CARLOS SLIM DE LA SALUD, A.C.
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 1 to 333. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333333 of 333 identical, no gaps.
-
JP 2019526262-A2019-09-19
Genetically Modified Bacteria
Intrexon Actobiotics NV
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 333, hit 1 to 333. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333333 of 333 identical, no gaps.
Family of 2
Grouped by a shared priority claim, US 62/383079.
- JP 2019526262-A2019-09-19
- JP 2024047590-A2024-04-05
-
US 10513563-B22019-12-24
Method for uses of proinsulin transferrin fusion proteins as prodrugs
University of Southern California
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 60 to 392. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 60 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 119 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 120 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 179 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 180 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 239 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 240 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 299 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 300 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 359 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 360 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 392333 of 333 identical, no gaps.
-
US 10772863-B22020-09-15
Methods of inducing metabolic maturation of human pluripotent stem cells- derived hepatocytes
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 86 to 418. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 86 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 145 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 146 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 205 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 206 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 265 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 266 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 325 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 326 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 385 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 386 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 418333 of 333 identical, no gaps.
-
WO 2020239995-A12020-12-03
INSULIN GENE THERAPY
UNIV AUTONOMA DE BARCELONA
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 1 to 333. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333333 of 333 identical, no gaps.
-
US 10858663-B22020-12-08
Genetically modified bacteria stably expressing IL-10 and insulin
INTREXON ACTOBIOTICS N.V.
Query Match 100.0%Identity 100.0%Family of 3
Best alignment and family
Query 1 to 333, hit 1 to 333. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333333 of 333 identical, no gaps.
Family of 3
Grouped by the same title and applicant. No priority claim is on record.
- US 10858663-B22020-12-08
- US 11549118-B22023-01-10
- US 12359210-B22025-07-15
-
US 11111535-B22021-09-07
Probes, libraries and kits for analysis of mixtures of nucleic acids and methods for constructing the same
QIAGEN GmbH
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 60 to 392. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 60 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 119 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 120 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 179 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 180 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 239 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 240 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 299 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 300 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 359 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 360 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 392333 of 333 identical, no gaps.
-
US 11149284-B22021-10-19
Transgenic cloned piglet expressing human proinsulin and method of producing the same
MGENPLUS CO., LTD.
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 1297 to 1629. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1297 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 1356 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1357 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 1416 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1417 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 1476 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1477 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 1536 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1537 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 1596 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 1597 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 1629333 of 333 identical, no gaps.
-
KR 1020220016100-A2022-02-08
INSULIN GENE THERAPY
UNIVERSITAT AUTONOMA DE BARCELONA
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 1 to 333. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333333 of 333 identical, no gaps.
-
US 11260081-B22022-03-01
Engineered parasites for delivering protein to the central nervous system (CNS)
Ramot at Tel-Aviv University Ltd. and The Universitv Court of the University of Glasgow
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 60 to 392. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 60 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 119 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 120 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 179 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 180 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 239 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 240 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 299 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 300 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 359 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 360 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 392333 of 333 identical, no gaps.
-
JP 2022524081-A2022-04-27
HUMAN CARBONIC ANHYDRASE 2 COMPOSITIONS AND METHODS FOR TUNABLE REGULATION
OBSIDIAN THERAPEUTICS INC
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 234 to 566. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 234 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 293 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 294 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 353 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 354 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 413 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 414 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 473 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 474 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 533 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 534 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 566333 of 333 identical, no gaps.
-
JP 2022534733-A2022-08-03
Insulin gene therapy
Universitat Autonoma de Barcelona
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 333, hit 1 to 333. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333333 of 333 identical, no gaps.
Family of 2
Grouped by a shared priority claim, EP 19382447.1.
- JP 2022534733-A2022-08-03
- JP 2025106333-A2025-07-15
-
US 11446398-B22022-09-20
Regulated biocircuit systems
OBSIDIAN THERAPEUTICS, INC.
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 234 to 566. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 234 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 293 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 294 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 353 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 354 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 413 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 414 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 473 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 474 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 533 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 534 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 566333 of 333 identical, no gaps.
-
KR 1020230087436-A2023-06-16
MODIFIED INSULIN AND GLUCOKINASE NUCLEIC ACIDS FOR TREATING DIABETES
KRIYA THERAPEUTICS, INC.
Query Match 100.0%Identity 100.0%Family of 3
Best alignment and family
Query 1 to 333, hit 1 to 333. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333333 of 333 identical, no gaps.
Family of 3
Grouped by a shared priority claim, US 63/047965.
- KR 1020230087436-A2023-06-16
- JP 2023542241-A2023-10-05
- JP 2026034616-A2026-02-27
-
JP 2023553341-A2023-12-21
YEAST-BASED EXPRESSION OF THERAPEUTIC PROTEINS IN VIVO
ESPEROVAX INC
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 1 to 333. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333333 of 333 identical, no gaps.
-
WO 2024147344-A2024-07-11
Patent application sequence for WO 2024147344-A/10
Juntendo Educational Foundation
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 1 to 333. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333333 of 333 identical, no gaps.
-
KR 1020240120749-A2024-08-07
GENE THERAPIES FOR METABOLIC DISORDERS
FRACTYL HEALTH, INC
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 333, hit 1 to 333. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333333 of 333 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020240120749-A2024-08-07
- JP 2025500891-A2025-01-15
-
KR 1020250076429-A2025-05-29
Metabolic disease therapeutic agent comprising carrier based on metal nanoparticle-nucleic acid conjugate
NES Biotechnology Co., Ltd
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 333, hit 862 to 1194. Positions start at 1 and include both ends.
Query 1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 862 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 921 Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 922 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 981 Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 180 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 982 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGAC 1041 Query 181 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 240 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1042 CTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTG 1101 Query 241 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 300 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| Hit 1102 GCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGC 1161 Query 301 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333 ||||||||||||||||||||||||||||||||| Hit 1162 TCCCTCTACCAGCTGGAGAACTACTGCAACTAG 1194333 of 333 identical, no gaps.